🎯 Septic Shock, Hemodynamic Support, A Neutral Trial with Important Lessons

🎯 Septic Shock, Hemodynamic Support, A Neutral Trial with Important Lessons

From Dr RR Baliga's "Got Knowledge Doc" Podkast by Dr RR Baliga, MD, MBA

June 12, 2026 · 4 min

About this episode

This episode discusses the ARISE FLUIDS trial and its implications for fluid management in septic shock.

🚑 How much fluid is too much in septic shock? The ARISE FLUIDS trial tackled one of critical care's most debated questions: should clinicians prioritize early vasopressors with restricted fluids or continue a more liberal fluid strategy? 📊 Among 963 patients with septic shock, early vasopressors reduced fluid exposure by >1 liter and significantly lowered pulmonary edema (0.6% vs 5.0%; P 🎯 Yet there was no difference in 90-day days alive and out of hospital or mortality. A landmark study reminding us that in septic shock, physiology is complex and more fluid is not always better—but less fluid is not necessarily superior either. #Sepsis #CriticalCare #EmergencyMedicine #NEJM #MedicalEducation

People in this episode

Host: Dr RR Baliga

Topics covered

  • septic shock
  • hemodynamic support
  • critical care
  • fluid management
  • medical education

Keywords

  • septic shock
  • fluid management
  • ARISE FLUIDS trial
  • critical care
  • vasopressors
  • pulmonary edema
  • medical education

Mentioned in this episode

Organizations: NEJM

Places: Australia

More episodes of Dr RR Baliga's "Got Knowledge Doc" Podkast

Explore listener stats, chart rankings, contacts and more on the Dr RR Baliga's "Got Knowledge Doc" Podkast podcast page.